Communicate with BC government about conditions under which innovative drugs and vaccines are marketed and reimbursed in BC, including under the BC Drug Plans or under federal legislation. In particular, communicating with respect to the integration of biosimilar drugs into the BC Drug Plans and to emphasize the importance that federal and provincial governments respect their respective jurisdiction for approval of marketing and reimbursement of drugs.
|
- Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly
- Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
- Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
- Decision by the Executive Council or a member of the Executive Council to have the private sector instead of the Crown provide goods or services to the government of British Columbia or a Provincial entity
|
Health
|